Genetics in non-alcoholic fatty liver disease : The role of risk alleles through the lens of immune response

The knowledge on the genetic component of non-alcoholic fatty liver disease (NAFLD) has grown exponentially over the last 10 to 15 years. This review summarizes the current evidence and the latest developments in the genetics of NAFLD and non-alcoholic steatohepatitis (NASH) from the immune system's perspective. Activation of innate and or adaptive immune response is an essential driver of NAFLD disease severity and progression. Lipid and immune pathways are crucial in the pathophysiology of NAFLD and NASH. Here, we highlight novel applications of genomic techniques, including single-cell sequencing and the genetics of gene expression, to elucidate the potential involvement of NAFLD/NASH-risk alleles in modulating immune system cells. Together, our focus is to provide an overview of the potential involvement of the NAFLD/NASH-related risk variants in mediating the immune-driven liver disease severity and diverse systemic pleiotropic effects.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Clinical and molecular hepatology - 29(2023), Suppl vom: 05. Feb., Seite S184-S195

Sprache:

Englisch

Beteiligte Personen:

Sookoian, Silvia [VerfasserIn]
Pirola, Carlos J [VerfasserIn]

Links:

Volltext

Themen:

Genetics
HSD17B13
Immune system
Journal Article
Nonalcoholic steatohepatitis
PNPLA3
Review

Anmerkungen:

Date Completed 15.03.2023

Date Revised 23.03.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.3350/cmh.2022.0318

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM349845174